Hospice Quality Score Assessment Post Pharmacist Intervention
NCT ID: NCT04361669
Last Updated: 2022-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2020-04-22
2022-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Standardized Patient-Centered Medication Review in Home Hospice
NCT03972163
Pharmacist-led Interventions to Improve Medication Use
NCT05346770
The Impact of Pharmacist Recommendations on Quality of Care in Diabetic Patients
NCT00122421
Minimizing Risk and Maximizing Outcomes in Geriatric Patients Through Integrated Clinical Pharmacy Services in an Innovative Model of Community Practice
NCT01351441
A Pharmacist Implemented Pharmacogenomics Service in the Program of All-inclusive Care for the Elderly
NCT03257605
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Patients that receive pharmacist-delivered services in the pilot program
Medication safety review
Implementation of a medication safety review using a clinical decision support system
Control
Patients that do not receive pharmacist-delivered services in the pilot program
Medication safety review
Implementation of a medication safety review using a clinical decision support system
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Medication safety review
Implementation of a medication safety review using a clinical decision support system
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
88 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tabula Rasa HealthCare
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer Bingham, PharmD
Role: PRINCIPAL_INVESTIGATOR
Tabula Rasa HealthCare
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tabula Rasa HealthCare
Tucson, Arizona, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TRHC_RD_Hospice_2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.